SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amid intense speculation of an improved acquisition offer from Sanofi, following a rejected $16/share bid. The community is highly optimistic about upcoming Phase 3 data for AXPAXLI in wet AMD, fueling expectations for a substantial premium or strong independent commercialization, a sentiment reinforced by a recent high-profile CCO hire.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu Crypto is trending with a highly engaged community actively building out a unique permissionless brand, showcasing real-world products and initiatives. Despite broader market weakness, the community's strong conviction and continuous development efforts are driving conversation and positioning KENDU as a standout long-term play.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

The crypto community is intensely bullish on $SATOSHI, viewing it as the ultimate tokenization of the timeless Satoshi Nakamoto legacy and the identity of the entire industry. Widespread discussions center on its unparalleled cultural significance and potential to become a foundational blue-chip asset, offering a second chance at early Bitcoin-like gains as the "We are all Satoshi" movement gains global traction.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is trending as the community highlights recent tokenomics updates including token burns, product upgrades, and new exchange listings, fueling discussions about its low market cap and staking rewards driving potential growth within the AI crypto sector.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is trending as the community actively discusses its adoption by the U.S. Military for quantum-secure drones and the significant utility signaled by enterprise partners like FedEx, with many viewing current market dips as a prime buying opportunity amidst ongoing debate over its long-term potential.

Power Solutions International, Inc. engages in the design, manufacture, and trade of power systems and electrical power generation equipment. The firm provides integrated turnkey solutions to global original equipment manufacturers and end-user customers within the energy, industrial, and transportation end markets. The company was founded by Gary S. Winemaster, Kenneth J. Winemaster, and William Winemaster in February 1985 and is headquartered in Wood Dale, IL.

Power Solutions International Inc

Power Solutions International

Power Solutions International is trending due to record sales driven by increasing data center demand and recent analyst upgrades. The community is actively discussing the stock's pronounced volatility post-earnings, with many seeing buying opportunities while others express concern over insider selling and valuation in the essential AI power infrastructure sector.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart recently surpassed a $1 trillion market cap and entered the Nasdaq-100 index, fueling significant momentum as the company leverages AI and expands its e-commerce presence. While bulls anticipate continued growth and strong earnings, the community is actively debating its elevated valuation and potential volatility leading into its upcoming earnings report.

Cooper-Standard Holdings, Inc. engages in the manufacture of sealing and fluid handling systems, including fuel and brake delivery and fluid transfer systems. It operates through the following segments: Sealing Systems, Fluid Handling Systems, and Corporate, Eliminations and Other. The Sealing Systems segment consists of manufacturing products for interior vehicle protection, dust and noise intrusion. The Fluid Handling Systems segment includes products that help convey, connect, control, and communicate throughout the fluid systems. The Corporate, Eliminations and Other segment is for all other business activities. The company was founded in 2004 and is headquartered in Northville, MI.

Cooper-Standard Holdings Inc

Cooper-Standard Holdings is trending after reporting strong quarterly earnings that exceeded expectations, highlighting robust operational performance and significant new business awards, particularly in EV and hybrid platforms. The community is buzzing with bullish sentiment around the company's growth trajectory and debt refinancing efforts, though some vocal skeptics point to price action they perceive as manipulation despite improved fundamentals.

DigitalOcean Holdings, Inc. engages in the provision of providing cloud infrastructure. It operates through the following geographical segments: United States, Netherlands, Germany, Canada, Singapore, and Other. The company was founded in 2012 and is headquartered in Broomfield, CO.

DigitalOcean Holdings Inc

DigitalOcean is trending following impressive earnings and multiple analyst upgrades, prompting a re-rating as a vital player in the AI cloud sector. The community is actively discussing its strategic partnership with AMD and its position as a preferred platform for developing new agentic AI workloads, fueling expectations for substantial growth.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin (SWFTC) is trending as the community actively discusses its significant potential, fueled by its perceived undervaluation as an AI-integrated cross-chain exchange with a fully diluted, fixed supply, prompting many to anticipate a major breakout reminiscent of its past parabolic movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Korro Bio, Inc. (NASDAQ:KRRO) Given Average Rating of "Hold" by Brokerages

Shares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have earned an average recommendation of "Hold" from the ten research firms that are presently covering the stock, MarketBeat reports. One...

HC Wainwright Brokers Lower Earnings Estimates for Korro Bio

Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - HC Wainwright reduced their Q2 2026 earnings estimates for shares of Korro Bio in a research report issued to clients and investors on Thursday, January...

Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?

Korro Bio, Inc. (KRRO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Korro Bio Analyst Day: KRRO-121 RNA-Editing Candidate Targets Ammonia Control in UCD and HE

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing therapeutic candidate the company believes could provide a new approach to...

<ul class="summary-bullets"><li>H.C. Wainwright said KRRO-121 adds a second, "independently risk-mitigated asset as a call option."</li><li>Piper Sandler said it left the company’s analyst day on Tuesday with "strong conviction" for KRRO-121's probability of success.</li><li>Oppenheimer upgraded Korro Bio to ‘Outperform’ from ‘Perform’ with a $22 price target.</li></ul>Shares of Korro Bio Inc. (KRRO) jumped 13% on Thursday after multiple analysts upgraded the stock on optimism about the company’s new development candidate KRRO-121.Korro is now looking to study the drug in the treatment of hyperammonemia. The company said on Tuesday that it intends to file an application in the second half of 2026 to begin its first in-human trial for the candidate.<h2 class="st-heading-2">Analysts Chime In</h2>H.C. Wainwright upgraded Korro Bio to ‘Buy’ from ‘Neutral’ with a $20 price target, according to TheFly. The firm said KRRO-121 adds a second, "independently risk-mitigated asset as a call option."Korro shares are trading near a zero enterprise value, the analyst told investors in a research note. H.C. Wainwright believes KRRO-121 is not a read-through from KRRO-110,"so this is a truly independent shot on goal."Piper Sandler analyst Yasmeen Rahimi on Wednesday also upgraded Korro Bio to ‘Overweight’ from ‘Neutral’ with a price target of $30, up from $11. Piper said it left the company’s analyst day on Tuesday with "strong conviction" for KRRO-121's probability of success, it said.The firm is bullish ahead of KRRO-121's new drug filing in the second half of 2026, saying there is a "clear precedence for a regulatory path."Oppenheimer also upgraded Korro Bio to ‘Outperform’ from ‘Perform’ with a $22 price target. The firm believes the company's probability of success is now reset and that KRRO-121 offers a fresh, interesting story wherein RNA editing can thrive. The firm sees potential for significant upside.<h2 class="st-heading-2">Pivot From KRRO-110</h2>In November, Korro said that in its <a href="https://stocktwits.com/news-articles/markets/equity/korro-bio-stock-crashes-over-75-after-hours-on-drug-failure-downgrades-and-layoffs/cLPBNsbREdA">trial</a> evaluating KRRO-110 in the genetic disorder called Alpha-1 Antitrypsin Deficiency (AATD), it achieved functional protein production with a single administration, but it did not achieve the protein levels projected based on preclinical data.The lower-than-expected results prompted a 34% reduction in working and the company subsequently opted KRRO-121 as its next development candidate, for the potential treatment of patients with hyperammonemia.Hyperammonemia is a critical metabolic condition defined by abnormally elevated blood ammonia levels, commonly resulting from liver failure (cirrhosis) or inherited urea cycle disorders. It causes acute, severe neurological impairment—including encephalopathy, seizures, coma, and cerebral edema—and requires immediate medical intervention to prevent fatal brain damage.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around KRRO stock rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user said that a strong momentum setup is shaping up, adding that buyers are defending these levels and pushing higher.<stembedurl>https://www.stocktwits.com/topstockalerts/message/643304339</stembedurl><a href="https://stocktwits.com/symbol/KRRO">KRRO shares</a> have dropped 60% in the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/trump-administration-reportedly-ready-to-lay-out-crypto-law/cmyikhjR41I">Trump Administration Reportedly Ready To Lay Out Crypto Rules</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

KRRO Shares Jump 13% On Analyst Upgrades — What’s Driving The Optimism?

The company said on Tuesday that it intends to file an application in the second half of 2026 to begin its first in-human trial for its new development candidate KRRO-121. 

Equity

The company said on Tuesday that it intends to file an application in the second half of 2026 to begin its first in-human trial for its new development candidate KRRO-121. 


Korro Bio (NASDAQ:KRRO) Shares Down 5.9% - Here's What Happened

Korro Bio (NASDAQ:KRRO) Stock Price Down 5.9% - What's Next...

Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of "Hold" from Analysts

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) has been given an average recommendation of "Hold" by the ten analysts that are covering the company, Marketbeat Ratings reports. One research analyst...

Korro Bio (NASDAQ:KRRO) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen lowered Korro Bio from a "hold" rating to a "sell" rating in a research report on Saturday...

FY2025 EPS Estimates for Korro Bio Raised by HC Wainwright

Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - Equities researchers at HC Wainwright raised their FY2025 earnings per share estimates for Korro Bio in a report released on Thursday, November 13th. HC...

Cantor Fitzgerald Predicts Higher Earnings for Korro Bio

Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - Analysts at Cantor Fitzgerald lifted their FY2025 earnings per share estimates for shares of Korro Bio in a research report issued on Thursday, November...

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Korro Bio Inc.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

KRRO
Korro Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KRRO News

KRROKorro Bio Inc